{"nct_id":"NCT06191744","title":"Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-02-05","start_date_type":"ACTUAL","primary_completion_date":"2037-11","primary_completion_date_type":"ESTIMATED","completion_date":"2037-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GMAB"]}